IN2GREAT! PEDIATRIC THERAPY SERVICES, LTD. – Trademark Portfolio

Entity Type: 03

IN2GREAT! PEDIATRIC THERAPY SERVICES, LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include IN2GREAT!. The owner is based in Buffalo Grove, IL.

275 West Dundee Road

Buffalo Grove, IL 60089

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IN2GREAT!
IN2GREAT!
Registered 2020

Trademark Classifications

IN2GREAT! PEDIATRIC THERAPY SERVICES, LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does IN2GREAT! PEDIATRIC THERAPY SERVICES, LTD. have?

IN2GREAT! PEDIATRIC THERAPY SERVICES, LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does IN2GREAT! PEDIATRIC THERAPY SERVICES, LTD. file in?

IN2GREAT! PEDIATRIC THERAPY SERVICES, LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are IN2GREAT! PEDIATRIC THERAPY SERVICES, LTD.'s most well-known trademarks?

IN2GREAT! PEDIATRIC THERAPY SERVICES, LTD.'s registered trademark portfolio includes well-known marks such as IN2GREAT!. These are among 1 currently registered trademark in the portfolio.

What is IN2GREAT! PEDIATRIC THERAPY SERVICES, LTD.'s trademark registration success rate?

IN2GREAT! PEDIATRIC THERAPY SERVICES, LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.